BioAge Labs, Inc.
NASDAQ:BIOABiotechnology
+$0.47 today
- Market cap
- $179.59M
- Beta
- 0.95
- P/E (TTM)
- -9.7
- EPS (TTM)
- -$2.12
Volume 0.64M
Average 0.46M
BIOA Total Assets
Everything the company owns or controls; equal to total liabilities plus equity.
BioAge Labs, Inc.NASDAQ: BIOA
Total Assets · Q1 FY2026 · quarter ended Mar 2026
Total assets rises 15.7% from a year ago
Total assets stood at $397.65M at the end of Q1 FY2026, up 15.7% from a year earlier and up 34.8% from the prior quarter. Over 3 fiscal years it compounded at +118.1% a year.
Context
- Total assets increased in 1 of the last 3 fiscal years.
What to watch
Whether total assets keeps rising in the next quarterly balance sheet after a +15.7% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Total Assets history
USD · from the balance sheet
- Latest · FY2025
- 294.89M USD
- Year-over-year change
- -17.7%
- 3-year CAGR
- +118.1%
| Period | Period end | Total Assets | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 294.89M | -17.7% |
| FY2024 | 2024-12-31 | 358.23M | +1281.9% |
| FY2023 | 2023-12-31 | 25.92M | -8.8% |
| FY2022 | 2022-12-31 | 28.43M | — |
Total Assets vs competitors
How BIOA compares with its peers on the latest reported figures
- Peers report in different currencies, so total assets is compared through growth and rates rather than absolute size.
- Its year-over-year change of +15.7% is the 2nd highest of 9, against a peer median of -25.5%.
- Over three fiscal years its annual growth of +118.1% compares with a peer median of -15.5%.
| Company | Period | Latest balance | YoY | 3-year CAGR |
|---|---|---|---|---|
| Mar 2026 | CA$1.12B CAD | +21.9% | -13.8% | |
| Mar 2026 | CA$602.64M CAD | -28.9% | -13.4% | |
BIOABioAge Labs, Inc. | Mar 2026 | $397.65M USD | +15.7% | +118.1% |
| Mar 2026 | $395.96M USD | -22.1% | -20.3% | |
| Mar 2026 | $267.08M USD | -39.3% | -22.1% | |
| Dec 2025 | $232.18M USD | — | — | |
| Mar 2026 | $149.34M USD | -43.4% | -28.7% | |
| Mar 2026 | $148.15M USD | -10.3% | +12.2% | |
| Mar 2026 | $110.56M USD | -32.0% | -17.1% | |
| Mar 2026 | $98.66M USD | -13.5% | -12.1% | |
| Peer median (excluding BIOA) | — | -25.5% | -15.5% | |
Competitors are the stored peer set for BIOA. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
BioAge Labs, Inc.
NASDAQ:BIOA
Intrinsic Alpha fair value
Locked
Current Price
$4.77
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.